“…[14] Besides, 2, 3-dihydroquinazoline-4(1H)-one derivatives can act as key structural motifs to design the new category of highly valuable synthetic drug candidates owing to their important pharmacological properties. [15,16] Recent literature studies clearly shown that a variety of molecules containing 2, 3-dihydroquinazoline-4(1H)-one structural units exhibit a series of significant biological activities such as antitumor, anticancer, antibiotic, antibacterial, antidefibrillatory, antipyretic, and anticonvulsant [17][18][19] The condensation of aryl, alkyl and hetroaryl aldehydes or ketones with anthranil amide in the presence of acidic catalysts is a well-known approach for the synthesis of 2, 3-dihydroquinazoline-4(1H)-ones. [20] In recent times, a variety of catalysts and promoter or reagents for the synthesis of these compounds have been reported in the literature.…”